European independent pharma network Mundipharma has bought worldwide ... phase 3 trials in biliary tract cancer by EDO, a contract research company with a worldwide network of clinical ...

And last month Mundipharma bought rights to develop, market and manufacture cancer drug CAP7.1 from Germany’s CellAct. With contract research firm EDO it will develop CAP7.1, a prodrug of ...

Steve was formerly Director of Product Development at Mundipharma Research Limited with managerial responsibilities for the drug product pilot plant and analytical laboratories. He has executed global ...